NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Exosomics S.p.A.

Exosomics S.p.A.

Private
SienaHealthcare & Life Scienceshttps://www.exosomics.eu/

Last Round

Early Funding

May 16, 2017

Company Overview

Exosomics S.p.A. is a biotechnology company that develops exosome-based liquid biopsy technologies and diagnostic tests for cancer screening and monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

liquid biopsyexosome isolationliquid biopsy techextracellular vesiclesexosome researchmolecular diagnosticscancer diagnosticscancer screeningbiomarker discoveryprecision medicineimmuno-affinityRUOresearch-use-onlybiotech reagentsnano-flow cytometry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exosomics S.p.A. Comparables

Compare Exosomics S.p.A. with similar companies based on industry and business-model similarity.

Exosomics S.p.A. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellBio Scientific
81%
EValuate Diagnostics, Inc.
80%
Theoria Science, Inc.
79%

Exosomics S.p.A. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 16, 2017

Key People

Founding team and executive leadership

Antonio Chiesi

Founder and CEO

Founding Team

Exosomics S.p.A. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exosomics S.p.A. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exosomics S.p.A.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSiena
Employee Range5
Year Founded2011
Last FundingMay 16, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.